Oramed Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

Oramed Pharmaceuticals Inc. Investor Presentation Now Available for On-demand
                   Viewing at RetailInvestorConferences.com

Company invites individual and institutional investors to log-on to view
presentation

PR Newswire

NEW YORK, Feb. 11, 2013

NEW YORK, Feb. 11, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc.
(NASDAQ:ORMP) (http://www.oramed.com), a developer of oral drug delivery
systems, announced today that their February 7th RetailInvestorConferences.com
presentation is now available for on-demand viewing.

LINK: www.retailinvestorconferences.com > red "register/ watch event now"
button

Oramed's presentation will be available 24/7 for 90 days. Investors may
download shareholder materials from the "virtual trade booth" for the next
three weeks.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery
solutions for drugs and vaccines currently delivered via injection.
Established in 2006, Oramed's technology is based on over 30 years of research
by top research scientists at Jerusalem's Hadassah Medical Center. Oramed is
seeking to revolutionize the treatment of diabetes through its proprietary
flagship product, an orally ingestible insulin capsule (ORMD-0801) currently
approaching FDA-approved Phase 2 clinical trials, and with its oral exenatide
capsule (ORMD-0901; a GLP-1 analog), currently approaching Phase 1b/2a trials.
The company's corporate and R&D headquarters are based in Jerusalem.

About RetailInvestorConferences.com

Since 2010, RetailInvestorConferences.com, created by BetterInvesting (NAIC)
PR NewswireandMUNCmedia, has been the only monthly virtual investor
conference series that provides an interactive forum for presenting companies
to meet directly with retail investors using a graphically-enhanced online
platform.

Designed to replicate the look and feel of location-based investor
conferences, Retail Investor Conferences unites PR Newswire's leading-edge
online conferencing and investor communications capabilities with
BetterInvesting's extensive retail investor audience network and MUNCmedia's
sophisticated retail investor targeting.

SOURCE Oramed Pharmaceuticals Inc.

Website: http://www.oramed.com
Contact: Oramed Pharmaceuticals: Aviva Sherman, +972-2-566-0001,
aviva@oramed.com or RetailInvestorConferences.com: Bradley H. Smith,
+1-201-942-7157, bradley.smith@prnewswire.com